C/T conversion alters interleukin-1A promoter function in a human astrocyte cell line

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• A polymorphism in the interleukin-1A (IL-1A) promoter (-889, T/T genotype) has been linked to Alzheimer's disease (AD).
• This suggests a potential role for IL-1A in AD pathogenesis.

Purpose of the Study:

• To investigate the functional mechanism of the IL-1A promoter polymorphism in relation to AD.
• To compare the transcriptional activity of the IL-1A promoter with different nucleotide variants.

Main Methods:

• Utilized the SVG astroglia cell line for promoter function analysis.
• Employed luciferase-reporter assays to measure transcriptional activity in response to IL-1A promoter variants.
• Assessed the effects of sodium salicylate and lovastatin on promoter activity.

Main Results:

• Cytosine/thymine conversion at the -889 locus significantly increased IL-1A promoter activity in SVG cells.
• Both sodium salicylate and lovastatin demonstrated inhibitory effects on the induced promoter activity.
• The T/T polymorphism may lead to increased IL-1A protein levels and "cytokine cycle" amplification.

Conclusions:

• The IL-1A promoter polymorphism (-889, T/T) enhances transcriptional activity, potentially contributing to AD development.
• This mechanism involves "cytokine cycle" amplification and can be modulated by compounds like sodium salicylate and lovastatin.